Alfonso Fernando
Unidad de Hemodinámica y Cardiología Intervencionista. Instituto Cardiovascular. Hospital Universitario Clínico San Carlos. Madrid.
Arch Cardiol Mex. 2010 Oct-Dec;80(4):272-82.
The main objective of biomedical journals is to publish high-quality scientific studies and to ensure a widespread dissemination of their contents, Journals compete for the best science generated in their respective disciplines and, therefore, they critically scrutinize the scientific quality of all submitted papers in order to identify and select only those thar merit publication. The "peer review" system represents the cornerstone of the scientific process. It provides a critical appraisal, by external independent experts, of the studies under consideration. The system is intended to improve the quality of the submitted papers but also to help the Editors in their decision-making process. The process has been widely embraced by the scientific and editorial onternational community but it is not free from caveats. In fact, although several strategies have been implemented to improve its quality and the results obtained, limitations still persist. Accordingly, its quality should be closely monitored to ensure excellence, limited scientific information exists on its real value. In this review we will critically analyze the "peer review" process and we will advance some ideas that may help to understand why, in spite of its limitations, it remains the "gold standar" for the selection of scientific manuscripts by biomedical journals.
生物医学期刊的主要目标是发表高质量的科学研究,并确保其内容得到广泛传播。期刊在各自学科领域中争夺最优秀的科研成果,因此,它们会严格审查所有投稿论文的科学质量,以便仅识别和选择那些值得发表的论文。“同行评审”系统是科学过程的基石。它由外部独立专家对所审议的研究进行批判性评估。该系统旨在提高投稿论文的质量,同时也有助于编辑进行决策。这一过程已被科学界和编辑界广泛接受,但也并非没有问题。事实上,尽管已经采取了多种策略来提高其质量和所取得的成果,但局限性仍然存在。因此,应密切监测其质量以确保卓越,然而关于其实际价值的科学信息有限。在本综述中,我们将批判性地分析“同行评审”过程,并提出一些观点,这些观点可能有助于理解为什么尽管存在局限性,但它仍然是生物医学期刊选择科学稿件的“黄金标准”。